IPO Timeline
Broker Results (T-2)
2023-06-28
Some brokers release in afternoon
Grey Market (T-1)
2023-06-29
Afternoon
HKEX Allotment (T-1)
2023-06-29
Evening
Registrar Allotment (T-1)
2023-06-29
Evening
Listing Day (T)
2023-06-30
First day of trading
Company Overview
| Stock Name | 艾迪康控股 |
|---|---|
| Stock Code | 09860 |
| Company Full Name | 艾迪康控股 |
| Industry | 醫療保健 |
| Principal Activities | 公司為中國三大獨立醫學實驗室（或ICL）服務提供商之一。 |
| Listing Date | 2023-06-30 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市西湖區振中路208號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.adicon.com.cn/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 12.32 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 71.2% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 40,902,400 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 6,160 |
| 2 lots | 1,000 | HK$ 12,320 |
| 3 lots | 1,500 | HK$ 18,480 |
| 4 lots | 2,000 | HK$ 24,640 |
| 5 lots | 2,500 | HK$ 30,800 |
| 6 lots | 3,000 | HK$ 36,960 |
| 7 lots | 3,500 | HK$ 43,120 |
| 8 lots | 4,000 | HK$ 49,280 |
| 9 lots | 4,500 | HK$ 55,440 |
| 10 lots | 5,000 | HK$ 61,600 |
| 12 lots | 6,000 | HK$ 73,920 |
| 14 lots | 7,000 | HK$ 86,240 |
| 16 lots | 8,000 | HK$ 98,560 |
| 18 lots | 9,000 | HK$ 110,880 |
| 20 lots | 10,000 | HK$ 123,200 |
| 30 lots | 15,000 | HK$ 184,800 |
| 40 lots | 20,000 | HK$ 246,400 |
| 50 lots | 25,000 | HK$ 308,000 |
| 60 lots | 30,000 | HK$ 369,600 |
| 70 lots | 35,000 | HK$ 431,200 |
| 80 lots | 40,000 | HK$ 492,800 |
| 90 lots | 45,000 | HK$ 554,400 |
| 100 lots | 50,000 | HK$ 616,000 |
| 140 lots | 70,000 | HK$ 862,400 |
| 180 lots | 90,000 | HK$ 1,108,800 |
| 200 lots | 100,000 | HK$ 1,232,000 |
| 400 lots | 200,000 | HK$ 2,464,000 |
| 600 lots | 300,000 | HK$ 3,696,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 13.8 |
|---|---|
| First Day Open | HK$ 12.32 |
| First Day Change | 12.01% |
| First Day Volume | 3373000.0 |
| First Day Turnover | 41794800.0 |
Use of Proceeds
| Use of Proceeds | 1、約12.6百萬港元（占15%）用于加強普檢及特檢能力，包括研發以及銷售及營銷能力； 2、約21.0百萬港元（占25%）通過新建實驗室、合伙投資及開發新渠道用于網絡拓展； 3、約21.0百萬港元（占25%）為業務開展工作與行業參與者形成戰略合作及戰略性及附加收購機會； 4、約12.6百萬港元（占15%）用于升級及擴大現有實驗室； 5、約8.4百萬港元（占10%）用于投資營運基礎設施，包括物流設施、人工智能技術及信息技術基礎設施； 6、約8.4百萬港元（占10%）作營運資金及一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
富瑞金融集团香港有限公司 CE ATS546
Overall Coordinators (6)
摩根士丹利亚洲有限公司 CE AAD291
富瑞金融集团香港有限公司 CE ATS546
中信里昂证券有限公司 CE AAB893
德意志银行香港分行
海通国际证券有限公司 CE AAF806
香港上海汇丰银行有限公司
Joint Bookrunners (12)
摩根士丹利亚洲有限公司 CE AAD291
富瑞金融集团香港有限公司 CE ATS546
中信里昂证券有限公司 CE AAB893
德意志银行香港分行
海通国际证券有限公司 CE AAF806
香港上海汇丰银行有限公司
建银国际金融有限公司 CE AJO225
富途证券国际（香港）有限公司 CE AZT137
华泰金融控股（香港）有限公司 CE AOK809
工银国际证券有限公司 CE ARO299
老虎证券（香港）环球有限公司 CE BMU940
华盛资本证券有限公司 CE AUL711
Joint Lead Managers (12)
摩根士丹利亚洲有限公司 CE AAD291
富瑞金融集团香港有限公司 CE ATS546
中信里昂证券有限公司 CE AAB893
德意志银行香港分行
海通国际证券有限公司 CE AAF806
香港上海汇丰银行有限公司
建银国际金融有限公司 CE AJO225
富途证券国际（香港）有限公司 CE AZT137
华泰金融控股（香港）有限公司 CE AOK809
工银国际证券有限公司 CE ARO299
老虎证券（香港）环球有限公司 CE BMU940
华盛资本证券有限公司 CE AUL711
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Corelink Group Limited | 26,512,640 HKD | — | 6.48% | — | 6 months | 2023-12-30 |
| 2 | Timestar Elite Limited | 29,697,360 HKD | — | 7.26% | — | 6 months | 2023-12-30 |
| 3 | 复星诊断科技(上海)有限公司 | 39,183,760 HKD | — | 9.58% | — | 6 months | 2023-12-30 |
| 4 | 迈瑞全球(香港)有限公司 | 117,563,600 HKD | — | 28.75% | — | 6 months | 2023-12-30 |
| 5 | 香港新产业生物有限公司 | 78,373,680 HKD | — | 19.17% | — | 6 months | 2023-12-30 |
Directors & Management
| Chairman | 楊凌 |
|---|---|
| Company Secretary | 王之翰;蘇嘉敏 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Pearl Group Limited(38.92%);Corelink Group Limited(12.45%);Mega Stream Limited(9.95%) |
|---|
Subscription Tiers
IPO Timeline
